| Title | Biomaker data |
|---|---|
| Description | An III phase, multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and tolerance of ROZANOLIXIZUMAB in adults with persistent or chronic primary immune thrombocytopenia (ITP) |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA013449 |
| Release Date | 2024-12-31 |
| Submitter | Ming Hou (houming@medmail.com.cn) |
| Organization | Qilu Hospital of Shandong University |
| Submission Date | 2022-11-24 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002449-01 | biomakerdata | 2 | Biomarker Data | 18.1 KB | zip | Controlled |
| OMIX002449-03 | Biomarker data for enrolled patients update | 1 | Biomarker Data | 77.5 KB | xlsx | Controlled |
| OMIX002449-04 | Biomarker Data_Unblinded | 1 | Biomarker Data | 82.6 KB | xlsx | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|